Related Experiment Video
Updated: Apr 14, 2026

08:10
The 6-hydroxydopamine Rat Model of Parkinson's Disease
Published on: October 27, 2021
13.7K
[SCA6 presenting parkinsonism without ataxia--A case report]
Shinichi Takeshima1, Ikuko Takeda, Keitaro Kobatake
1Department of Neurology, Brain Attack Center Ota Memorial Hospital.
Rinsho Shinkeigaku = Clinical Neurology
|April 24, 2015
Summary
A rare case of spinocerebellar ataxia type 6 (SCA6) presented with parkinsonism. This finding is crucial for understanding the complex mechanisms underlying neurodegenerative diseases.
Area of Science:
- Neurogenetics
- Neurology
- Molecular Medicine
Background:
- Parkinson disease (PD) is characterized by bradykinesia and typically responds to levodopa.
- Dopaminergic deficits in the nigrostriatal pathway are a hallmark of PD.
Observation:
- A 57-year-old man with bradykinesia showed poor levodopa response, atypical for PD.
- Brain imaging revealed cerebellar and cerebral atrophy, and reduced parietal lobe perfusion.
- Cardiac MIBG scintigraphy indicated reduced sympathetic innervation, and DAT imaging showed nigrostriatal damage.
Findings:
- Genetic testing identified spinocerebellar ataxia type 6 (SCA6) in the patient, his mother, and an uncle.
- The patient's presentation of parkinsonism without ataxia, linked to SCA6, is exceptionally rare.
Implications:
- This case highlights the phenotypic variability of SCA6, challenging typical diagnostic criteria.
- Understanding SCA6 with parkinsonism offers new insights into the pathogenesis of both ataxia and parkinsonian syndromes.
- Further research into SCA6 mechanisms may reveal novel therapeutic targets for neurodegenerative disorders.
Related Concept Videos
Parkinson's Disease: Overview
2.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.5K
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Neural Regulation
45.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
45.1K

